Listed times are in Central European Time (CET)

WELCOME TO DAY ONE

Session 1

Chair: Jyoti Nangalia

Ruth Travis Oxford University, UK

Q&A: 12:25-12:35

Paul Bastard University of Paris INSERM, France

'Can autoantibodies prevent or precipitate cancer?'

Q&A: 12:55-13:05

Proffered Paper 1

Q&A: 13:15-13:20

Proffered Paper 2

Q&A: 13:30-13:35

FLASH TALKS SESSION 1

REFRESHMENT BREAK

Session 2

Chair: Kamila Naxerova

Chi V Dang Ludvig cancer research, USA

Q&A: 14:25-14:35

Proffered Paper 3

Q&A: 14:45-14:50

FLASH TALKS SESSION 2

REFRESHMENT BREAK

Proffered Paper 4

Q&A: 15:30-15:35

Proffered Paper 5

Q&A: 15:45-15:50

Closing Keynote Lecture

Tobias Janowitz Cold Spring Harbor Laboratory, USA

'Interorgan communication and germline-encoded autoimmunity during cancer progression'

Q&A: 16:20-16:35

SUMMARY AND CLOSE

Listed times are in Central European Time (CET)

WELCOME TO DAY TWO

Session 3

Chair: Paul Bastard

Matthias Kloor Heidelberg University, Germany

Q&A: 12:25-12:35

Jyoti Nangalia Wellcome Sanger Institute, UK

'The evolution of the methylome in blood and relevance to clonal haematopoiesis and haematological malignancies.'

Q&A: 12:55-13:05

Proffered Paper 6

Q&A: 13:15-13:20

Proffered Paper 7

Q&A: 13:30-13:35

REFRESHMENT BREAK

Session 4

Chair: Chi Van Dang

FLASH TALKS SESSION 3

Proffered Paper 8

Q&A: 14:15-14:20

Kara Maxwell University of Pennsylvania, USA

Q&A: 14:40-14:50

REFRESHMENT BREAK

FLASH TALKS SESSION 4

Kamila Naxerova Harvard Medical School, USA

'Limiting tissue turnover to avoid cancer'

Q&A: 15:40-15:50

Discussion Session

Karl Smith-Byrne Oxford, UK

'Patient perspectives on cancer avoidance'

SUMMARY AND CLOSE